PI-RADS V2 as a Prostate Cancer Detectability Tool is it Dependable for Usage in Diagnosis?

Background: Prostate Imaging Reporting and Data System (PI-RADS) is a scoring system that aims to enable consistent interpretation, communication, and reporting of prostate multiparametric MRI (mpMRI) findings.

Aim: To evaluate and investigate the upgrade of the multi-parametric MRI prostate besides the role of PIRADS as a reporting and grading system in prostatic diseases.

Methodology: A clinical research trial conducted on 52 male study subjects having prostatic symptoms (from February 2015 till October 2016), the research was conducted within the radiology department of the Kasr AL-Ainy hospitals, and Egyptian national cancer institute. Cases recruited were referred from the Outpatient clinics of the urology department.

Results: All cases 100% of pathologically proven carcinoma were suspected to be in the peripheral zone by MRI, with T2 scoring PIRADS 3 were 8 cases ( 24.2%), PIRADS 4 were 12 cases (36.4%) and PIRADS 5 were 13 cases (39.4%).Only 3 cases had mild hemorrhage after TRUS guided biopsy with no major symptomatic adverse effects noted.

Conclusions: Multi-parametric MRI prostate is cornerstone advanced tool for diagnosis and gives better results in the diagnosis of prostatic diseases. PIRADS is an efficient way to help in the diagnosis that will result resulting in better management and aids in guiding TRUS biopsy for better visualization of lesions pre-biopsy leading to more precise biopsy and accurate diagnosis.